PDUFA Old School: Industry Wants User Fees To Get Back To Basics
This article was originally published in The Pink Sheet Daily
Executive Summary
User fees should be spent on improving drug assessments, not funding everybody's wish list for FDA action, Genzyme policy advisor tells DIA